仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Camidanlumab （HuMax-TAC） is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates （ADCs） to research several diseases including lymphoma and leukemia